Hybrid (Sativa-leaning)

Blue Dream | Cannabis Strain Review & Effects

Also known as: Blueberry Dream, Azure Haze

Blueberry x Haze

Blue Dream is a hybrid-leaning sativa strain (Blueberry x Haze) with THC levels of 17-24%. It features a Myrcene-dominant terpene profile and is known for relaxation and euphoria. Best used during the afternoon.

THC

17-24%

CBD

0.1-2%

Best Time

Afternoon

Primary Effects

RelaxationEuphoriaCreativityPain Relief

Flavor Notes

Sweet berry, Blueberry, Herbal, Vanilla

Aroma

Sweet blueberry and fresh berries with subtle herbal undertones

Research Sources

29 peer-reviewed studies

Verified Via

PubMed / DOI

Evidence

Research-Backed

Updated

December 2025

Every claim cites peer-reviewed research
How We Research

What is Blue Dream?

Blue Dream is a hybrid-leaning sativa strain (Blueberry x Haze) with THC levels of 17-24%. It features a Myrcene-dominant terpene profile and is known for relaxation and euphoria. Best used during the afternoon.

About Blue Dream Strain

Blue Dream is one of the most popular strains in the United States, known for its balanced effects that combine full-body relaxation with gentle cerebral invigoration. The high myrcene content contributes to its relaxing properties, while pinene may help maintain mental clarity. Its versatile effects make it suitable for both novice and experienced users.

Related Reading

Terpene Profile

Myrcenedominant
Earthy, musky, clove-like~0.85%

Primary research: Sedation & Relaxation

Pineneprimary
Fresh pine, forest, evergreen~0.45%

Primary research: Mental Clarity

Spicy, peppery, woody, clove-like~0.25%

Primary research: Anti-inflammatory

Concentration Levels

Dominant (>1.0%)
Primary (0.5-1.0%)
Secondary (0.1-0.5%)
Trace (<0.1%)

Cannabinoid Profile

THCPsychoactive

17-24%

Pain Relief

0.1-2%

Seizure Reduction

Therapeutic Profile Matches

Based on Blue Dream's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:

migraines

63%
Moderate Match
  • High myrcene content supports migraines & headaches
  • thc dominant ratio matches profile
  • Best used afternoon, aligning with condition needs

chronic pain

60%
Moderate Match
  • High myrcene content supports chronic pain
  • Best used afternoon, aligning with condition needs

multiple sclerosis

56%
Moderate Match
  • High myrcene content supports multiple sclerosis
  • Best used afternoon, aligning with condition needs

muscle spasms

55%
Moderate Match
  • High myrcene content supports muscle spasms & spasticity
  • High beta-caryophyllene content supports muscle spasms & spasticity

epilepsy

53%
Moderate Match
  • High beta-caryophyllene content supports epilepsy & seizures
  • Best used afternoon, aligning with condition needs

Match scores are theoretical

These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.

  1. 1

    Surendran S, et al. Myrcene-What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition. 2021

    Comprehensive review: β-myrcene may potentiate the anti-nociceptive properties of cannabinoids.

  2. 2

    Johnson MB, et al. The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study Cannabis. 2023

    Found myrcene alone did not significantly impair simulated driving performance.

  3. 3

    do Vale TG, et al. Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) n.e. Brown Phytomedicine. 2002

    Demonstrated dose-dependent sedative and motor-relaxant effects of myrcene in mice.

  4. 4

    Lorenzetti BB, et al. Myrcene mimics the peripheral analgesic activity of lemongrass tea Journal of Ethnopharmacology. 1991

    Found peripheral analgesic activity in animal models.

  5. 5

    Liktor-Busa E, et al. Analgesic Potential of Terpenes Derived from Cannabis sativa Pharmacological Reviews. 2021

    Comprehensive review of cannabis terpene analgesic effects including myrcene.

  6. 6

    Perry NS, et al. In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes Journal of Pharmacy and Pharmacology. 2000

    Pinene and other terpenes inhibit AChE with memory implications.

  7. 7

    Ding Y, et al. Eucalyptol, limonene and pinene enteric capsules attenuate airway inflammation and obstruction in lipopolysaccharide-induced chronic bronchitis rat model via TLR4 signaling inhibition Phytomedicine. 2024

    Pinene attenuates airway inflammation and obstruction.

  8. 8

    Nam SY, et al. The therapeutic efficacy of α-pinene in an experimental mouse model of allergic rhinitis International Immunopharmacology. 2014

    α-Pinene reduced IgE-mediated allergic inflammation.

  9. 9

    Salehi B, et al. Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature Biomolecules. 2019

    Most comprehensive review of pinene pharmacology.

  10. 10

    Gertsch J, et al. β-Caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences. 2008

    Landmark paper: BCP directly activates CB2 receptors.

  11. 11

    Klauke AL, et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain European Journal of Pain. 2014

    Showed dual mechanism for neuropathic pain relief.

  12. 12

    Bahi A, et al. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice Physiology & Behavior. 2014

    BCP reduced anxiety via CB2 receptor activation.

  13. 13

    Horvath B, et al. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner Free Radical Biology and Medicine. 2012

    BCP reduced inflammation markers and oxidative stress.

  14. 14

    Tambe Y, et al. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene Planta Medica. 1996

    BCP protected gastric mucosa in ulcer models.

  15. 15

    Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046

    Landmark paper first identifying and synthesizing THC.

  16. 16

    Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015

    Comprehensive review finding moderate evidence for chronic pain.

  17. 17

    Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Pain Physician. 2017

    Systematic review of clinical trials for neuropathic pain.

  18. 18

    Lutge EE, et al. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database of Systematic Reviews. 2013

    Systematic review of cannabis for HIV/AIDS symptoms including appetite.

  19. 19

    Smith LA, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy Cochrane Database of Systematic Reviews. 2015

    High-quality evidence for CINV efficacy.

  20. 20

    Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep Frontiers in Molecular Neuroscience. 2020

    Review of THC effects on sleep architecture.

  21. 21

    Novotna A, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis European Journal of Neurology. 2011

    Phase III trial showing efficacy for MS spasticity.

  22. 22

    Silvestro S, et al. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease Molecules. 2020

    Comprehensive review of CBD's therapeutic applications and molecular targets.

  23. 23

    Thiele EA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial Lancet. 2018

    Phase III trial leading to FDA approval of Epidiolex.

  24. 24

    Devinsky O, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurology. 2016

    Open-label trial showing 36.5% reduction in seizures.

  25. 25

    Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019

    79.2% of patients reported reduced anxiety within first month.

  26. 26

    Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients Neuropsychopharmacology. 2011

    CBD reduced anxiety in simulated public speaking test.

  27. 27

    Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation Bioorganic & Medicinal Chemistry. 2015

    Review of CBD's anti-inflammatory mechanisms.

  28. 28

    Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series Permanente Journal. 2019

    66.7% of patients reported improved sleep in this anxiety and sleep study.

  29. 29

    Urits I, et al. Use of cannabidiol (CBD) for the treatment of chronic pain Best Practice & Research Clinical Anaesthesiology. 2020

    Comprehensive review of CBD for chronic pain management.

Research Verification

All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.

Frequently Asked Questions

What are the effects of Blue Dream?

Blue Dream provides balanced effects combining relaxation with gentle mental stimulation. Users commonly report feeling relaxed, euphoric, and creative. Its myrcene-dominant profile promotes calm while pinene may support focus.

Is Blue Dream good for beginners?

Yes, Blue Dream is often recommended for beginners due to its balanced, manageable effects. The high is typically described as gentle and approachable, with less chance of anxiety compared to more potent strains.

What does Blue Dream taste like?

Blue Dream has a sweet, berry-like flavor with prominent blueberry notes inherited from its Blueberry parent. Many users also detect subtle vanilla and herbal undertones.

Quick Facts

Type
Hybrid (Sativa-leaning)
Genetics
Blueberry x Haze
Breeder
DJ Short (Blueberry lineage)
Genetic Family
Blueberry Family
Best Time of Use
Afternoon
Availability
common
Grow Difficulty
moderate

Want to try Blue Dream? Get your medical marijuana card today.

Get Your Card

Educational Information

This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.

Strain Variability

Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.

Beyond Indica/Sativa

Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.

Understanding Therapeutic Profiles

Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.

Learn About Therapeutic Profiles